276 related articles for article (PubMed ID: 2383282)
1. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition by aminoglycoside antibiotics--I. Biochemical analysis.
Mingeot-Leclercq MP; Piret J; Brasseur R; Tulkens PM
Biochem Pharmacol; 1990 Aug; 40(3):489-97. PubMed ID: 2383282
[TBL] [Abstract][Full Text] [Related]
2. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition induced by aminoglycoside antibiotics--II. Conformational analysis.
Mingeot-Leclercq MP; Piret J; Tulkens PM; Brasseur R
Biochem Pharmacol; 1990 Aug; 40(3):499-506. PubMed ID: 2383283
[TBL] [Abstract][Full Text] [Related]
3. Effect of substrate organization on the activity and on the mechanism of gentamicin-induced inhibition of rat liver lysosomal phospholipase A1.
Piret J; Kishore BK; Tulkens PM
Biochem Pharmacol; 1992 Feb; 43(4):895-8. PubMed ID: 1540243
[TBL] [Abstract][Full Text] [Related]
4. Interaction of streptomycin and streptomycylamine derivatives with negatively charged lipid layers. Correlation between binding, conformation of complexes and inhibition of lysosomal phospholipase activities.
Brasseur R; Carlier MB; Laurent G; Claes PJ; Vanderhaeghe HJ; Tulkens PM; Ruysschaert JM
Biochem Pharmacol; 1985 Apr; 34(7):1035-47. PubMed ID: 3985990
[TBL] [Abstract][Full Text] [Related]
5. Biochemical mechanism of aminoglycoside-induced inhibition of phosphatidylcholine hydrolysis by lysosomal phospholipases.
Mingeot-Leclercq MP; Laurent G; Tulkens PM
Biochem Pharmacol; 1988 Feb; 37(4):591-9. PubMed ID: 3342096
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: in vitro comparative studies.
Carlier MB; Laurent G; Claes PJ; Vanderhaeghe HJ; Tulkens PM
Antimicrob Agents Chemother; 1983 Mar; 23(3):440-9. PubMed ID: 6847172
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity.
Van Bambeke F; Montenez JP; Piret J; Tulkens PM; Courtoy PJ; Mingeot-Leclercq MP
Eur J Pharmacol; 1996 Oct; 314(1-2):203-14. PubMed ID: 8957238
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.
Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P
Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of kidney lysosomal phospholipase A1 by aminoglycosides is a novel variant of substrate depletion inhibition.
Hostetler KY; Jellison EJ
J Pharmacol Exp Ther; 1990 Jul; 254(1):188-91. PubMed ID: 2366181
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural, physico-chemical and conformational study of the interactions of gentamicin and bis(beta-diethylaminoethylether) hexestrol with negatively-charged phospholipid layers.
Mingeot-Leclercq MP; Schanck A; Ronveaux-Dupal MF; Deleers M; Brasseur R; Ruysschaert JM; Laurent G; Tulkens PM
Biochem Pharmacol; 1989 Mar; 38(5):729-41. PubMed ID: 2539158
[TBL] [Abstract][Full Text] [Related]
11. Interactions of aminoglycoside antibiotics with negatively charged lipid layers. Biochemical and conformational studies.
Brasseur R; Laurent G; Ruysschaert JM; Tulkens P
Biochem Pharmacol; 1984 Feb; 33(4):629-37. PubMed ID: 6704179
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the in vitro activity of lysosomal phospholipase A1 by membrane lipids.
Piret J; Schanck A; Delfosse S; Van Bambeke F; Kishore BK; Tulkens PM; Mingeot-Leclercq MP
Chem Phys Lipids; 2005 Jan; 133(1):1-15. PubMed ID: 15589222
[TBL] [Abstract][Full Text] [Related]
14. Molecular parameters involved in aminoglycoside nephrotoxicity.
Mingeot-Leclercq MP; Brasseur R; Schanck A
J Toxicol Environ Health; 1995 Mar; 44(3):263-300. PubMed ID: 7897692
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity.
Hostetler KY; Hall LB
Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1663-7. PubMed ID: 6951205
[TBL] [Abstract][Full Text] [Related]
16. Aminoglycoside antibiotics preferentially increase permeability in phosphoinositide-containing membranes: a study with carboxyfluorescein in liposomes.
Au S; Weiner ND; Schacht J
Biochim Biophys Acta; 1987 Aug; 902(1):80-6. PubMed ID: 3038190
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of lysosomal phospholipases by aminoglycoside antibiotics: a comparative study.
Carlier MB; Laurent G; Tulkens P
Arch Toxicol Suppl; 1984; 7():282-5. PubMed ID: 6595993
[TBL] [Abstract][Full Text] [Related]
18. Aminoglycoside antibiotics inhibit lysosomal phospholipase A and C from rat liver in vitro.
Hostetler KY; Hall LB
Biochim Biophys Acta; 1982 Mar; 710(3):506-9. PubMed ID: 7074128
[TBL] [Abstract][Full Text] [Related]
19. Hydrolysis of phosphatidylcholine liposomes by lysosomal phospholipase A is maximal at the phase transition temperature of the lipid substrate.
Vandenbranden M; De Gand G; Brasseur R; Defrise-Quertain F; Ruysschaert JM
Biosci Rep; 1985 Jun; 5(6):477-82. PubMed ID: 4041563
[TBL] [Abstract][Full Text] [Related]
20. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models.
Montenez JP; Van Bambeke F; Piret J; Brasseur R; Tulkens PM; Mingeot-Leclercq MP
Toxicol Appl Pharmacol; 1999 Apr; 156(2):129-40. PubMed ID: 10198278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
